Digital Therapeutics Market Size | Trends Reshaping Healthcare in 2025

Q: What is the overall size of the digital therapeutics market?

The digital therapeutics market is projected to reach USD 16.9 billion by 2031.

Q: Which patient segments benefit most from digital therapeutics?

Patients with chronic illnesses such as diabetes, depression, COPD, and anxiety disorders benefit the most from DTx interventions.

Q: What is the market compound annual growth rate for digital therapeutics market?

The market is expected to grow at a CAGR of 15.9% for the upcoming years.

Q: What role do healthcare providers play in digital therapeutics?

Clinicians are essential for prescribing, monitoring, and integrating digital therapeutics into patient treatment plans, especially when used alongside traditional therapies.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA4619

Publication Date: Jul 2025

What is the Digital Therapeutics Market Size?

According to 6Wresearch internal database and industry insights, the Global digital therapeutics market was estimated to be worth USD 6.1 billion in 2024 and is projected to reach USD 16.9 billion by 2031. The market is anticipated to grow at a robust CAGR of 15.9% during the forecast period.

This growth is primarily driven by the rising prevalence of chronic diseases, growing acceptance of non-pharmaceutical treatment options, and expanding regulatory support for software-based therapies that deliver evidence-based interventions.

Key Growth Factors of the Digital Therapeutics Market

Growing number of chronic diseases like diabetes, obesity, and hypertension worldwide
Increasing the use of behavioural modification therapies and their awareness
Increasing the extent to which digital therapies are integrated into healthcare payer and provider systems
Positive reimbursement guidelines and regulatory clearances for DTx products
Utilising wearable technology and smartphones extensively to administer treatment programs
Encouragement of remote patient interaction and personalised medicine

Digital Therapeutics Market Trends

The market is witnessing the development of disease-specific apps backed by clinical evidence, especially for mental health, metabolic disorders, and substance use disorders. Partnerships between pharma companies and digital health startups are accelerating go-to-market strategies. There is growing emphasis on real-world evidence (RWE) generation to support DTx efficacy and reimbursement. Integration with electronic health records (EHRs) and remote monitoring tools is also becoming standard.

Emerging Developments in the Digital Therapeutics Market

Digital therapeutics platforms are increasingly incorporating gamification and cognitive behavioral therapy (CBT) features to boost patient adherence. Regulatory agencies such as the FDA and EMA are providing more structured frameworks for approval. AI-based personalization engines are being embedded in DTx programs to optimize patient outcomes. Startups are also exploring DTx for underserved indications like insomnia, PTSD, and ADHD. Data privacy and cybersecurity enhancements are being prioritized to ensure compliance and trust.